Isracann Bioscience Inc. (ISCNF)

[StockRoomBully]

Behold, Isracann, with the pending ticker IPOT.C.

Israel, as anyone who has ever been on a kibbutz can confirm, has a long and happy history with weed – both the growing, and the consuming. And often the consuming while growing what you’re consuming.

When any Canadian LP wants to show they’re up on the latest research and tech in the cannabis space, they’ll often look to find Israeli experts to bring aboard, or companies to acquire, or JV with.

While Israeli tech is serious business, it’s the growing where things get interesting, because no western country has a climate more suited to the plant than you’ll find in Israel.

But who has the ability to grow there?

¤ You’d need a license – not an application, but a real actual license.

¤ And you’d need land you could build greenhouses on.

¤ And you’d need the money to build those greenhouses.

Isracann has all three. In fact, it has agreements with three Israeli license holding farms, and it has a fully funded greenhouse capacity of 232k sq ft, and 348k sq ft more to grow into later.


have a business plan, but I want to see runs on the board.

So who are these guys?

Daryl Jones is President and CEO. You may recall him from being the guy who took True Leaf (MJ.C) public in 2014, and exiting three years later with a 15x profit.

Marc Zegal is Chairman. He’s the local market knowledge, having founded and financed several Israeli pubcos, including the $120m market cap Rada Electronics (RADA.Q), and being a former member of the Chicago Board of Exchange.

Israel Moseson is COO, and has been in Israeli cannabis for five years currently.
Brett Allan, who was part of the team that brought Emblem Health (EMC.V), Organigram (OGI.T), and Green Organic Dutchman (TGOD.T) public, is an advisory board member.

Deepak Anand is another advisor. He’s executive director of the Canadian National Medical Marijuana Association, a former VP of Cannabis Compliance, and knows everybody who’s anybody in Canadian weed.

https://equity.guru/2019/04/12/isracann-biosciences-ipot-c-tgod-israel-gathers-large-early-retail-investor-base/